Is NHI a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Redeploying the NHC sale proceeds, with revenue (ttm) at ~$376 million. The bear case rests on the clearest near-term risk is redeployment drag: guidance was already cut roughly 4% on the asset sale, and proceeds sitting in cash or paying down debt earn far less than the assets that were sold. Analysts covering it are spread from $74.00 to $91.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The clearest near-term risk is redeployment drag: guidance was already cut roughly 4% on the asset sale, and proceeds sitting in cash or paying down debt earn far less than the assets that were sold. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $74.00, -1.7% from the $75.30 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Redeploying the NHC sale proceeds. The $560 million from the skilled nursing sale is the single biggest swing factor in the next several quarters. The most optimistic analyst target on NHI is $91.00, +20.8% from the $75.30 price. That figure is only reachable if this thesis works close to its best case.

The clearest near-term risk is redeployment drag: guidance was already cut roughly 4% on the asset sale, and proceeds sitting in cash or paying down debt earn far less than the assets that were sold. Concentration remains real even after the NHC exit, since a handful of operators including Bickford, Senior Living Communities and the National Health Corporation relationship still account for a large share of revenue, and an operator in distress can force a rent reset or a transition. Moving toward SHOP structurally increases earnings volatility, because labor inflation, insurance costs and occupancy swings hit NHI directly rather than being absorbed by a tenant. As a REIT with a payout obligation, NHI is also sensitive to long-term interest rates on two fronts: higher rates raise refinancing and acquisition hurdle costs, and they compete directly with the dividend yield for income-oriented capital. Finally, senior housing assets face physical and reimbursement risk in the remaining non-private-pay exposure, where policy changes to Medicaid or Medicare rates can pressure the operators that pay the rent. The most pessimistic published target is $74.00, -1.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Healthcare REIT owning senior housing and medical properties, leased to operators on a triple-net basis.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Redeploying the NHC sale proceeds) stalling in the reported numbers rather than in the narrative, the risk above (the clearest near-term risk is redeployment drag: guidance was already cut roughly 4% on the asset sale, and proceeds sitting in cash or paying down debt earn far less than the assets that were sold) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

A portfolio of senior housing and healthcare real estate across the United States: independent living, assisted living, memory care, entrance-fee communities and medical properties. After the July 2026 sale of 32 skilled nursing facilities and three independent living communities to National HealthCare Corporation, the mix skews more toward private-pay senior housing than toward government-reimbursed skilled nursing.

The reduction from a range of ~$4.94 to ~$4.99 down to ~$4.74 to ~$4.79 per diluted share is mostly mechanical. Selling $560 million of income-producing assets removes their rent from the run rate immediately, while the proceeds take time to redeploy into new investments at comparable yields. Transaction costs of roughly $6 million to $8 million were also expected on the deal.

SHOP stands for Senior Housing Operating Portfolio. Instead of leasing a building to an operator for fixed rent, the REIT takes the property-level revenue and expenses and hires a manager. Pro forma, SHOP is around 22% of NHI's total investments and roughly 14% of annualized net operating income. It raises both the upside from rising occupancy and the downside from wage or insurance inflation.